🟢 Context Therapeutics is trading 7% up with no clear company-specific catalyst

Context Therapeutics is trading at $0.36, up 6.98%, with no clear company-specific catalyst identified for October 6.

• The company’s press-release page lists September 9 as its latest 2026 announcement.
• The Nasdaq is up 0.57% and the S&P 500 is up 0.50%; this may support a broader risk-on backdrop but does not establish the direct cause of the stock’s move.